CASI
CASI Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.15
+3.08%Margins
Gross margin
35.8%
EBITDA margin
-154.1%
EBIT margin
-168.0%
Net margin
-183.9%
FCF margin
0.0%
172.7%
Return on equity
-201.9%
Return on assets
463.1%
Return on invested capital
0.96x
Asset turnover
$0.00
Cash from operations
$0.29
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2025